JPRN-UMIN000045611已完成未知
Impact of Anamorelin with unresectable pancreatic, gastric and colorectal cancer patients for a quality of life, skeletal muscle index and malnutrition - Impact of Anamorelin for unresectable patients with pancreatic, gastric and colorectal cancer
Asahikawa Medical University Department of Medicine, Division of Metabolism and Biosystemic Science, Gastroenterology, and Hematology0 个研究点目标入组 194 人开始时间: 2021年10月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 194
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Patients who receives Anamorelin treatment 1) under 20 years old 2) Patients with severe cardiac disease 3) Patients with severe liver disease (Child-Pugh B or C) 4) Patients with severe psychologic disease 5) Patients who is taking medications as follows; Clarithromycin, Indinavir, Itraconazole, Nelfinavir, Saquinavir, Telaprevir, Voriconazole, Ritonavir-containing agent or Cobicistat-containing agent 6) Unable to oral intake due to gastrointestinal occlusion or other organic gastrointestinal disorders 7) Unable to take part in this study due to other severe complication 8) Disqualified to take part in this study judged by attending/primary doctors 9) Patients with congestive heart failure, myocardial infarction, angina pectoris or severe cardiac conduction abnormalities 2. Patients who does not receive Anamorelin treatment 1) under 20 years old 2) Patients with severe cardiac disease 3) Patients with severe liver disease (Child-Pugh B or C) 4) Patients with severe psychologic disease 5) Unable to oral intake due to gastrointestinal occlusion or other organic gastrointestinal disorders 6) Unable to take part in this study due to other severe complication 7) Disqualified to take part in this study judged by attending/primary doctors When the patient is determined not to qualify taking part in this study after the registration, the patients will be excluded from the study immediately.
研究者
相似试验
招募中
不适用
Prospective study for the effects of pancreatic enzyme replacement therapy on quality of life and nutritional assessment after pancreas resectioDiseases of the digestive systemKCT0000010Seoul National University232
已完成
不适用
Implications of curative pancreatectomy for pancreatic cancer with positive peritoneal washing cytologypancreatic cancerJPRN-UMIN000023532Ministry of Education, Culture, Sports, Science and Technology2,500
招募中
不适用
Pancreatic Locally advanced Irresectable Cancer AblatioN (PELICAN trial)Locally advanced pancreatic cancernon-resectabel pancreatic tumor10017998NL-OMON56404Amsterdam UMC174
进行中（未招募）
不适用
Pancreatic cancer operation and development of diabetesCTRI/2013/12/004233AIIMS84
招募中
不适用
The influence of pancreatic function on the pharmacokinetics of ivacaftor in patients with cystic fibrosismucoviscidosisCystic FibrosisNL-OMON51011HagaZiekenhuis20